These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 26290208)

  • 1. Polysaccharide-Based Nanocarriers for Ocular Drug Delivery.
    Formica ML; Calles JA; Palma SD
    Curr Pharm Des; 2015; 21(33):4851-68. PubMed ID: 26290208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
    Sharma Y; Patel P; Kurmi BD
    Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
    Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
    Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
    Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
    Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
    Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
    Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular application of chitosan.
    Başaran E; Yazan Y
    Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid in ocular drug delivery.
    Zhang X; Wei D; Xu Y; Zhu Q
    Carbohydr Polym; 2021 Jul; 264():118006. PubMed ID: 33910737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
    Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
    Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
    Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
    Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
    Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
    Wang R; Gao Y; Liu A; Zhai G
    J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new generation of polymer nanoparticles for drug delivery.
    Chauvierre C; Vauthier C; Labarre D; Couvreur P; Marden MC; Leclerc L
    Cell Mol Biol (Noisy-le-grand); 2004 May; 50(3):233-9. PubMed ID: 15209344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotherapies for the treatment of ocular diseases.
    Reimondez-Troitiño S; Csaba N; Alonso MJ; de la Fuente M
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):279-93. PubMed ID: 25725262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, development and optimization of oral colon targeted drug delivery system of azathioprine using biodegradable polymers.
    Nath B; Nath LK
    Pharm Dev Technol; 2013; 18(5):1131-9. PubMed ID: 23167303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophilic matrix sustained release systems based on polysaccharide carriers.
    Melia CD
    Crit Rev Ther Drug Carrier Syst; 1991; 8(4):395-421. PubMed ID: 1769067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.